SEC Company Response from VANGUARD WORLD FUND (CIK 0000052848) — Aug 19, 2025
VANGUARD WORLD FUND (CIK 0000052848)
Date: Aug. 19, 2025 · CIK: 0000052848 · Accession: 0001683863-25-006801
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 811-01027
Letter
Re: Vanguard World Fund (the “Trust”) File Nos. 2-17620; 811-01027 Preliminary Proxy Statement Filed on August 11, 2025
Dear Ms. Larkin,
This letter responds to your comments provided on August 15, 2025, to the above referenced preliminary proxy statement that was filed with the Commission on August 11, 2025 for the Vanguard Health Care Index Fund and Vanguard Financials Index Fund, each a series of the Trust, to seek shareholder approval to become nondiversified under the meaning of the Investment Company Act of 1940.
Comment 1:
Proposals 1 and 2 – General
Comment:
The Staff requests that we please note that, in the future, preliminary proxy
materials should be clearly marked as “preliminary copies” as required by Rule
14A-6 subsection E.
Response:
This comment is noted and this disclosure will be added in connection with any
subsequent preliminary proxy filings.
Comment 2:
Proposals 1 and 2 – Details on the Proposals
Comment:
Under the heading “How will changing the Funds diversification under the 1940
Act benefit the funds?,” please consider revising the sentence that states, “Each
Fund’s Benchmark Index has increasingly become concentrated in a smaller
number of issuers and is currently nondiversified…” to better reflect that indices
cannot be nondiversified as they are not governed by the Investment Company Act
of 1940 diversification requirements.
Response:
The disclosure has been revised accordingly.
P.O. Box 2600
Valley Forge, PA 19482
jane_hongshissler@vanguard.com
Please do not hesitate to contact me at jane_hongshissler@vanguard.com with any questions or comments regarding the above responses.
Sincerely,
/s/ Jane Hong Shissler
Show Raw Text
CORRESP 1 filename1.htm correspondence P.O. Box 2600 Valley Forge, PA 19482 jane_hongshissler@vanguard.com via electronic filing August 19, 2025 Lisa N. Larkin, Esq. U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Vanguard World Fund (the “Trust”) File Nos. 2-17620; 811-01027 Preliminary Proxy Statement Filed on August 11, 2025 Dear Ms. Larkin, This letter responds to your comments provided on August 15, 2025, to the above referenced preliminary proxy statement that was filed with the Commission on August 11, 2025 for the Vanguard Health Care Index Fund and Vanguard Financials Index Fund, each a series of the Trust, to seek shareholder approval to become nondiversified under the meaning of the Investment Company Act of 1940. Comment 1: Proposals 1 and 2 – General Comment: The Staff requests that we please note that, in the future, preliminary proxy materials should be clearly marked as “preliminary copies” as required by Rule 14A-6 subsection E. Response: This comment is noted and this disclosure will be added in connection with any subsequent preliminary proxy filings. Comment 2: Proposals 1 and 2 – Details on the Proposals Comment: Under the heading “How will changing the Funds diversification under the 1940 Act benefit the funds?,” please consider revising the sentence that states, “Each Fund’s Benchmark Index has increasingly become concentrated in a smaller number of issuers and is currently nondiversified…” to better reflect that indices cannot be nondiversified as they are not governed by the Investment Company Act of 1940 diversification requirements. Response: The disclosure has been revised accordingly. 1 P.O. Box 2600 Valley Forge, PA 19482 jane_hongshissler@vanguard.com Please do not hesitate to contact me at jane_hongshissler@vanguard.com with any questions or comments regarding the above responses. Sincerely, /s/ Jane Hong Shissler Jane Hong Shissler Associate General Counsel The Vanguard Group, Inc. 2